ライフサイエンスコーパス: AIP

1 AIP does not affect long-term survival.

2 AIP inhibits IRF7 function by antagonizing the nuclear l

3 AIP is a rare disease whose recognition and understandin

4 AIP neurons responding to outline shapes also responded

5 AIP was also tested on induced pluripotent stem cells de

6 AIP-1 overexpression also reduced accumulation of Abeta

7 AIP-directed mitochondrial import of survivin did not af

8 Patients with type 1 AIP have a high relapse rate, but patients with type 2 A

9 Type 1 AIP is the pancreatic manifestation of a systemic fibroi

10 At presentation, patients with type 1 AIP were older than those with type 2 AIP (62 +/- 14 vs

11 and vital status of 78 patients with type 1 AIP who met the original HISORt criteria and 19 patients

12 In type 1 AIP, proximal biliary involvement (hazard ratio [HR], 2.

13 a mutation in Caenorhabditis elegans AIPR-1 (AIP-related-1), which causes profound increases in evoke

14 Types 1 and 2 AIP have distinct clinical profiles.

15 iles and long-term outcomes of types 1 and 2 AIP.

16 type 1 AIP were older than those with type 2 AIP (62 +/- 14 vs 48 +/- 19 years; P < .0001) and had a

17 Type 2 AIP affects younger patients, does not have a gender pre

18 re geared toward diagnosis of type 1; type 2 AIP can be definitively diagnosed only on pancreatic his

19 high relapse rate, but patients with type 2 AIP do not experience relapse.

20 atients with histologically confirmed type 2 AIP.

21 IP receptors AgrC and the AIPs, as AP4-24H11.AIP-4 binding recapitulates features that have been prop

22 The agonist, AIP-I, binds AgrC-I noncooperatively in a 2:2 stoichiome

23 s, AgrB-AgrD processing inhibitors, and AgrC-AIP interaction inhibitors.

24 es features that have been proposed for AgrC-AIP recognition.

25 Biochemical analysis of chimeric AIPL1-AIP proteins supported this model and also revealed a co

26 Therefore, an AIP-Tom20 recognition contributes to cell survival in de

27 pon Staphylococcus lugdunensis AIP-1 (1) and AIP-2 (2) displayed respective IC50 values of 0.2 +/- 0.

28 ) of 0.95], chronic pancreatitis (0.86), and AIP (0.99).

29 Interestingly, AIRAPL and AIP-1 contain a predicted farnesylation site, which is a

30 mportant roles of both cerebellar cortex and AIP nucleus in eyeblink conditioning were seen.

31 function from thiolactone ring formation and AIP transport.

32 ctrometry and discovered that the AIP-II and AIP-III signals are 12 residues in length, making them t

33 d IRF7 is enhanced upon virus infection, and AIP potently inhibits IRF7-induced type I IFN (IFNalpha/

34 al and anterior intraparietal areas (MIP and AIP), and parietal area PEip; somatosensory areas S1 and

35 mbined group of N, chronic pancreatitis, and AIP was determined.

36 t is shown to be under dorsolateral (PMv and AIP) more than dorsomedial control, and under SPL7, soma

37 peptide regions important for processing and AIP secretion.

38 The parietal area AIP operated primarily in a visual mode.

39 rmed by macaque anterior intraparietal area (AIP) and hand area (F5) of the ventral premotor cortex i

40 primates are in anterior intraparietal area (AIP) and ventral premotor cortex (PMv).

41 tions, with the anterior intraparietal area (AIP) playing a major role in routing information about o

42 comprising the anterior intraparietal area (AIP), ventral premotor (PMv), and primary motor cortex (

43 activity in the anterior intraparietal area (AIP).

44 nvolved in tuber-sprouting such as ARF, ARP, AIP and ERF.

45 ocated anterior to the angular gyrus such as AIP and VIP are less medially displaced relative to maca

46 An association between AIP and the human leukocyte antigen (HLA)-DRB1*0405/DQB1

47 The interaction between AIP and IRF7 is enhanced upon virus infection, and AIP p

48 ed studies confirm the intimate link between AIP production and intracellular AgrD(C) levels.

49 s a survivin 1-141 mutant that does not bind AIP was not imported to mitochondria and failed to inhib

50 ormation about object properties provided by AIP.

51 ctrometric analysis identified the S. caprae AIP as an eight-residue peptide (YSTCSYYF).

52 therapeutic efficacy of synthetic S. caprae AIP was evident by a dramatic reduction in both dermonec

53 ering the activation efficacy of the cognate AIP-1.

54 Consistently, AIP-deficient murine embryonic fibroblasts are highly re

55 led two key structural elements that control AIP-III (and non-native peptide) activity: (1) a tri-res

56 More detailed studies with the convenient AIP model indicated that CSF-1 neutralization led to a r

57 gative I-Abeta chain(-/-) (Ab0) mice develop AIP spontaneously, likely due to dysregulation of CD8(+)

58 HLA-DR*0405 transgenic Ab0 NOD mice develop AIP with high prevalence after sublethal irradiation and

59 indicate that (1)H NMR can help to diagnose AIP attacks based on the identification of ALA and PBG.

60 groups I-IV), each of which uses a different AIP:AgrC pair.

61 wly published strategies for differentiating AIP from pancreatic cancer are available.

62 ractions [10-12] were modified by disrupting AIP function with theta-burst TMS (cTBS) [13].

63 y, whereas patients with homozygous dominant AIP (HD-AIP) have early-onset chronic neurological impai

64 s explain the chemical principles that drive AIP production, including uncovering a hitherto unknown

65 During AIP, delta-aminolevulinic acid (ALA) accumulates and pro

66 s with SDB, which could be blocked by either AIP or KN93 (N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-

67 tructures of the three native S. epidermidis AIP signals and five non-native analogs with distinct ac

68 d analogue of the Staphylococcus epidermidis AIP-1 (3) elicited an IC50 value of 2.7 +/- 0.1 muM.

69 the minimum effective shape feature evoking AIP responses.

70 aration were significantly reduced following AIP cTBS without directly modifying corticospinal excita

71 A novel antibody for AIP has recently been identified and its performance nee

72 Diagnostic criteria for AIP are based on histology, imaging, serology, extrapanc

73 c biopsy of the bile duct was diagnostic for AIP in 88% patients.

74 tion via a thiolactone bond is essential for AIP function; therefore, recognition of the cyclic form

75 e appears to be an important risk factor for AIP on the HLA-DRB1*0405/DQB1*0401 haplotype.

76 ne in the rate of operative intervention for AIP, a steroid-responsive disease with propensity for re

77 ponsive genes and suggests that a search for AIP-dependent, AHR-responsive genes may guide us to the

78 orticoids have become a standard therapy for AIP, but the indications requiring treatment as well as

79 oid therapy improve the diagnostic yield for AIP.

80 When decoding from AIP, F5, and M1 combined, the mean accuracy was 50% (usi

81 R*0405 expression fails to protect mice from AIP, the HLA-DRB1*0405 allele appears to be an important

82 predicted well during movement planning from AIP (medial array) and F5 (lateral array), whereas M1 pr

83 tify and quantify ALA and PBG in urines from AIP patients and (2) to identify metabolites that would

84 Intravascular delivery of AAV9-GFP-AIP to adolescent mice transduced ~50% of cardiomyocytes

85 Administration of AAV9-GFP-AIP to neonatal mice with a known CPVT mutation (RYR2(R1

86 AAV9-GFP-AIP was robustly expressed in the heart without signific

87 We developed AAV9-GFP-AIP, an adeno-associated viral vector in which a potent

88 as patients with homozygous dominant AIP (HD-AIP) have early-onset chronic neurological impairment, i

89 manifestations, knock-in mice with human HD-AIP missense mutations c.500G>A (p.Arg167Glu) or c.518_5

90 er, these studies suggest that the severe HD-AIP neurological phenotype results from decreased myelin

91 residual HMBS activity and the heterozygous AIP phenotype.

92 However, little is known about how AIP contributes to the processing of grasp-related infor

93 It is unclear how AIP binding regulates AgrC activity.

94 nfavorable, and therefore, it is unclear how AIP-producing bacteria produce sufficient amounts of the

95 ning the object shape, but it is unknown how AIP neurons actually represent object shape.

96 Human AIP heterozygotes have episodic acute neurovisceral atta

97 2_844delGAG) identical to that causing human AIP and two missense mutations, c.250G>A (p.A84T) and c.

98 fe-threatening neurological attacks in human AIP and the evaluation of therapeutic strategies.

99 We created a mouse model of human AIP by overexpressing lymphotoxin (LT)alpha and beta spe

100 is, diagnostic markers, and therapy of human AIP.

101 Here, we have identified AIP (aryl hydrocarbon receptor interacting protein) as a

102 g peptide (AIP) signals has been identified (AIP-I), and cross talk between agr systems has not been

103 Together, our study identifies AIP as a novel inhibitor of IRF7 and a negative regulato

104 reported a set of analogues of the group-III AIP that are capable of strongly modulating the activity

105 reversible mislocalization of ductal CFTR in AIP, the association of asymptomatic pancreatic hyperenz

106 mutagenized and screened for deficiencies in AIP production.

107 ral other antibodies have been identified in AIP against pancreas-specific antigens like trypsinogens

108 of grasp-related and spatial information in AIP and F5 suggests at least a supportive role of these

109 activity from many electrodes in parallel in AIP and F5 while three macaque monkeys (Macaca mulatta)

110 ghout the task, although more prominently in AIP than in F5.

111 or management and prevention of relapses in AIP.

112 aze and target positions were represented in AIP and F5 and could be readily decoded from single unit

113 Whether these spatial signals in AIP and F5 also play a causal role for the planning of r

114 1 residues were defective in a later step in AIP biosynthesis, separating the peptidase function from

115 umor-derived cytokine CCL5 is upregulated in AIP-mutation-positive human adenomas.

116 CACS were markedly elevated with increasing AIP quartile in participants with baseline CACSs of 0 an

117 esidues glutamate 34 or leucine 41 inhibited AIP production and AgrB activity.

118 e fully reversed by acute CaMKII inhibition (AIP [autocamtide-2 related inhibitory peptide]).

119 expressing the SR-targeted CaMKII inhibitor AIP, without any significant enhancement of apoptosis vs

120 Non-native ligands capable of intercepting AIP:AgrC binding, and thereby QS, in S. aureus have attr

121 Interestingly, AIP of HIV-1 Env glycoproteins were found to correlate i

122 e we report that the anterior intraparietal (AIP) and the rostral ventral premotor area (F5) in the m

123 The macaque anterior intraparietal (AIP) area has been implicated in the extraction of affor

124 ng activity from the anterior intraparietal (AIP), ventral premotor (F5), and primary motor (M1) cort

125 es were distributed among four laboratories (AIP, NCS, LSPQ, and SSI).

126 2 stoichiometry, while an antagonist ligand, AIP-II, functions as an inverse agonist of the kinase ac

127 Herein, we report amide-linked AIP analogues with greatly enhanced hydrolytic stabiliti

128 logues based upon Staphylococcus lugdunensis AIP-1 (1) and AIP-2 (2) displayed respective IC50 values

129 e rescued by presynaptic expression of mouse AIP, demonstrating that a conserved function of AIP prot

130 utocamtide-2-related inhibitory peptide (myr-AIP)--but not by inhibition of the activity of protein p

131 ) blockers applied by bath (KN-93, myristoyl-AIP) or expressed selectively in the sensory neurons (AI

132 onal structural analysis of the known native AIP signals (AIPs-I-IV) and several AIP-III analogues wi

133 A limited set of non-native AIP analogs have been shown to inhibit AgrC receptors; s

134 s-potent AgrC-I modulators and in the native AIP-I itself.

135 xpressed selectively in the sensory neurons (AIP) reduced CDF, unlike their inactive analogues.

136 levations (>140 mg/dl) are seen in 70-80% of AIP patients and also in 5% of normal population and 10%

137 in S. aureus by sensing the accumulation of AIP via the histidine kinase AgrC and the response regul

138 utable to higher-than-normal accumulation of AIP-III in a codY mutant strain, as determined using ult

139 emistry for the diagnosis of acute attack of AIP and identify urinary glycin as a potential marker of

140 The biosynthesis of AIP requires AgrD, the peptide precursor of AIP, and the

141 ed as a hub that shared the visual coding of AIP only temporarily and switched to highly dominant mot

142 of the severity of a chronic complication of AIP.

143 dressed this by studying the consequences of AIP "virtual lesions" on physiological interactions betw

144 actors that contribute to the development of AIP and new therapeutic strategies.

145 le of single HLA genes in the development of AIP in transgenic mice.

146 identify recent advances in the diagnosis of AIP and evaluate outcomes with various diagnostic strate

147 Behaviorally, disruption of AIP was also associated with a relative loss of the gras

148 tural insights may enable the engineering of AIP cross-reactive antibodies or quorum quenching vaccin

149 cilitate the optimal processing or export of AIP for signal amplification through AgrC/A and inductio

150 (i) The expression of AIP in hepatocytes is essential to maintain high levels

151 l immune-complex deposition, and features of AIP in Ela1-LTab mice.

152 owever, when combined with other features of AIP, it can be of great diagnostic value though its util

153 y in acinar cells of mice causes features of AIP.

154 autoimmune disorder with various features of AIP.

155 were homozygous, a unique recessive form of AIP.

156 h was suppressed by a cell-permeable form of AIP.

157 , demonstrating that a conserved function of AIP proteins is to inhibit calcium release from ryanodin

158 uced activation of IFN, whereas knockdown of AIP by siRNA potentiates virally activated IFN productio

159 1 protected against, while RNAi knockdown of AIP-1 exacerbated, Abeta toxicity.

160 Pancreatic and biliary manifestations of AIP mimic pancreaticobiliary cancers.

161 strong structural support for a mechanism of AIP-mediated AgrC activation and inhibition in S. aureus

162 The mechanisms of AIP-dependent pituitary tumorigenesis are still under in

163 In addition, microinjection of AIP into the PVN significantly reduced arterial blood pr

164 Misdiagnosis of AIP can result in major surgery for a steroid-responsive

165 he first naturally occurring animal model of AIP in four unrelated cat lines who presented phenotypic

166 t plays a key role in the invasive nature of AIP-mutation-positive tumors and the CCL5/CCR5 pathway i

167 Overexpression of AIP blocks virus-induced activation of IFN, whereas knoc

168 sgenic model, we show that overexpression of AIP-1 protected against, while RNAi knockdown of AIP-1 e

169 AIP requires AgrD, the peptide precursor of AIP, and the integral membrane endopeptidase AgrB.

170 ospital survey from Japan, the prevalence of AIP was estimated at 0.82 per 100,000 individuals.

171 lycin as a potential marker of recurrence of AIP acute attacks.

172 sociations that may predispose to relapse of AIP were reported.

173 enetic screen may help to predict relapse of AIP.

174 To understand the role of AIP in adaptive and toxic aspects of AHR signaling, we g

175 A subset of AIP neurons is also activated by two-dimensional images

176 design, synthesis, and biological testing of AIP-III mimetics.

177 gress made in the diagnosis and treatment of AIP in the past year.

178 be an advantage in the medical treatment of AIP-dependent human acromegaly.

179 ces in the past year in our understanding of AIP.

180 driven genes show differential dependence on AIP expression.

181 This differential dependence on AIP provides evidence that the mammalian genome contains

182 ide dismutase, whereas its inhibitor KN93 or AIP abolished the arrhythmic phenotype.

183 G4) is a feature of autoimmune pancreatitis (AIP) and IgG4-associated cholangitis (IAC); a >2-fold in

184 isting knowledge of autoimmune pancreatitis (AIP) and to review the progress made in the diagnosis an

185 e concentrations in autoimmune pancreatitis (AIP) by restoring mislocalized CFTR protein to the apica

186 s may differentiate autoimmune pancreatitis (AIP) from pancreatic cancer in select patients.

187 Autoimmune pancreatitis (AIP) has been divided into subtypes 1 (lymphoplasmacytic

188 Autoimmune pancreatitis (AIP) is a rare and underdiagnosed fibrosclerosing inflam

189 Autoimmune pancreatitis (AIP) is the pancreatic manifestation of ISD and mimics p

190 Autoimmune pancreatitis (AIP) underlies 5%-11% of cases of chronic pancreatitis.

191 or the diagnosis of autoimmune pancreatitis (AIP) with the objective of establishing a strategy to di

192 genic mechanisms of autoimmune pancreatitis (AIP), an increasingly recognized, immune-mediated form o

193 es of patients with autoimmune pancreatitis (AIP), and follow-up periods have generally been short.

194 ronic pancreatitis, autoimmune pancreatitis (AIP), and healthy controls (N).

195 allel in macaque premotor (F5) and parietal (AIP) cortices during a delayed grasping task revealed th

196 tive inhibitors of the autoinducing peptide (AIP) activated AgrC receptor, by altering the activation

197 ine kinase detects its autoinducing peptide (AIP) ligand and generates an intracellular signal result

198 duction and sensing of autoinducing peptide (AIP) signal molecules by the agr locus.

199 and the binding of an autoinducing peptide (AIP) signal to its cognate transmembrane receptor (AgrC)

200 s, but only one of the autoinducing peptide (AIP) signals has been identified (AIP-I), and cross talk

201 pathogen that utilizes autoinducing peptide (AIP) signals to mediate QS and thereby regulate virulenc

202 ning peptide called an autoinducing peptide (AIP) that is biosynthesized from the AgrD precursor by t

203 ted that the S. caprae autoinducing peptide (AIP) was responsible, and mass spectrometric analysis id

204 analogues of a native autoinducing peptide (AIP-III) signal that can inhibit AgrC-type QS receptors

205 sed in FRD-SR-autocamide inhibitory peptide (AIP) mice, expressing the SR-targeted CaMKII inhibitor A

206 or autocamtide-2-related inhibitory peptide (AIP) normalized the increased amplitude of NMDAR-EPSCs a

207 questers the secreted agr-signaling peptide (AIP).

208 e, autocamtide-2-related inhibitory peptide [AIP], is fused to green fluorescent protein (GFP) and ex

209 In Ag-induced peritonitis (AIP), thioglycolate-induced peritonitis, and LPS-induced

210 the inferior parietal lobe such as PF, PFG, AIP, and the tip of the IPS.

211 ls with aggregation-induced phosphorescence (AIP) is designed, which exhibits two distinctly differen

212 sterol, and the atherogenic index of plasma (AIP) suggesting its hypolipidemic action.

213 ion between the atherogenic index of plasma (AIP), which has been suggested as a novel marker for ath

214 patients with acute intermittent porphyria (AIP) and porphyria cutanea tarda (PCT).

215 Acute intermittent porphyria (AIP) is an inborn error of heme biosynthesis due to the

216 patients with acute intermittent porphyria (AIP), an inherited metabolic disorder of heme biosynthes

217 patients with acute intermittent porphyria (AIP).

218 The Arabidopsis information portal (AIP), a resource expected to provide access to all commu

219 t to uncover the anterior intestinal portal (AIP) endoderm as a putative heart organizer.

220 d fuse above the anterior intestinal portal (AIP) to form the heart tube.

221 nvaginations-the anterior intestinal portal (AIP) towards the rostral end of the embryo and the cauda

222 d tested their apoptosis-inducing potential (AIP).

223 tios of aqueous-inlet to oil-inlet pressure (AIP/OIP), yielding a linear relationship between muaq an

224 ytes (Ela1-LTab/Ccr2(-/-)) failed to prevent AIP but prevented early pancreatic tissue damage.

225 The Arctic Investigations Program (AIP) began surveillance for invasive group A streptococc

226 ) and Alaska (Arctic Investigations Program [AIP]).

227 yl hydrocarbon receptor interacting protein (AIP) mutation-induced aggressive, young-onset growth hor

228 yl hydrocarbon receptor-interacting protein (AIP) mutations lead to somatotroph tumorigenesis in mice

229 yl hydrocarbon receptor-interacting protein (AIP), a co-chaperone protein, as required for response t

230 yl hydrocarbon receptor-interacting protein (AIP), a survivin-associated immunophilin, causes embryon

231 yl hydrocarbon receptor-interacting protein (AIP), also known as ARA9 and XAP2.

232 n E3 ligases atrophin-1-interacting protein (AIP)4 and AIP5.

233 uitin ligase atrophin-1 interacting protein (AIP)4 to bind, ubiquitinate, and stabilize Amot130.

234 In import assays using recombinant proteins, AIP directly mediated the import of survivin to mitochon

235 We recorded AIP neuronal activity from two macaques while they obser

236 Q active-site residues significantly reduces AIP signaling and attenuates virulence.

237 The Cyp1b1 and Ahrr genes require AIP expression for normal up-regulation by dioxin, where

238 were adequate to produce correct responses, AIP failed to adapt to perturbations.

239 At rest, AIP virtual lesions did not modify PMv-M1 interactions.

240 n native AIP signals (AIPs-I-IV) and several AIP-III analogues with varied biological activities usin

241 SHG-AIP with two symmetrical spots is found to be a signatur

242 on of second-order nonlinear emitters on SHG-AIP is highlighted.

243 SHG angular intensity pattern (SHG-AIP) of healthy and proteolysed muscle tissues are simul

244 We also show that SHG-AIP provides information on the three-dimensional struct

245 be a signature of healthy muscle whereas SHG-AIP with one centered spot in pathological mdx muscle is

246 When an extracellular peptide signal (AIP-III in strain UAMS-1, used for these experiments) re

247 esults demonstrated that binding of a single AIP molecule was sufficient to enhance filament severing

248 gnificant enhancement of apoptosis vs. CD-SR-AIP mice.

249 oxidative stress but not apoptosis in FRD-SR-AIP mice, in which a CaMKII inhibitor is targeted to the

250 eractions between the cognate staphylococcal AIP receptors AgrC and the AIPs, as AP4-24H11.AIP-4 bind

251 The term 'AIP' appears to encompass at least two distinct subtypes

252 ariance explained) significantly better than AIP (6%).

253 ion of variability in trial-to-trial RT than AIP.

254 effect on trial-to-trial RT variability than AIP.

255 Results confirmed that AIP fully attenuates caspase-3 activation for at least 8

256 Our study demonstrates that AIP of HIV-1 Env and IA collectively determine CD4 loss

257 We determined that AIP is also required for PDE3A-SLFN12 complex formation.

258 In this study, we have identified that AIP-mutation-positive tumors are infiltrated by a large

259 onal structure, although it is possible that AIP needs more training time to learn to generate novel

260 The AIP has value for predicting CAC progression in asymptom

261 The AIP level was associated with the annualized Delta trans

262 that active endodermal shortening around the AIP accounts for most of the heart field motion towards

263 the complexities of interaction between the AIP and PKA pathway.

264 evidence points to a connection between the AIP and PKA pathways.

265 d throughout the central region encoding the AIP signal.

266 adjusting for traditional risk factors, the AIP was significantly associated with CAC progression in

267 Taking advantage of the AIE feature, the AIP molecules are fabricated into OLEDs as a homogeneous

268 , we demonstrate two important roles for the AIP protein in AHR biology.

269 n December 2011 proposed a structure for the AIP to provide a framework for the minimal components of

270 Neurons in the AIP area respond during visually guided grasping and to

271 We now invite broader participation in the AIP development process so that the resource can be impl

272 frequently associated with mutations in the AIP gene and are sometimes associated with hypersecretio

273 wered inflammatory macrophage number; in the AIP model, this reduced number was not due to suppressed

274 with each of the four amide nitrogens in the AIP-4 macrocyclic ring.

275 these studies provide new insights into the AIP:AgrC interactions crucial for QS activation in S. ep

276 s challenge the current understanding of the AIP area as a critical stage in the dorsal stream for th

277 (ii) Expression of the AIP protein is essential for dioxin-induced hepatotoxici

278 Migration of the AIP to form foregut has been descriptively characterized

279 The design of the AIP will provide core functionality while remaining flex

280 this binding motif, (R/K)R(I/A/V) (L/P), the AIP box for Asf1-Interacting Protein box.

281 lethal dose of S. aureus by sequestering the AIP signal.

282 We show that the AIP can induce cardiac identity from non-cardiac mesoder

283 These findings suggest that the AIP integrates format-dependent information and the visu

284 ng mass spectrometry and discovered that the AIP-II and AIP-III signals are 12 residues in length, ma

285 This study investigated whether the AIP also contributes to invariant coding of OMAs across

286 d into four groups (I-IV) according to their AIP signal and cognate extracellular receptor, AgrC.

287 We structurally characterized all three AIP types using mass spectrometry and discovered that th

288 ere stratified into four groups according to AIP quartiles, which were determined by the log of (trig

289 tabolites that would predict the response to AIP crisis treatment and reflect differential metabolic

290 T cells; we compared their susceptibility to AIP with HLA-DQ8 or HLA-DR*0401 (single) transgenic, or

291 transgenic mice can also develop unprovoked AIP, whereas HLA-DR*0401, HLA-DQ8, and HLA-DR*0405/DQ8 t

292 ial variability and movement timing, whereas AIP might be more closely linked to overall movement int

293 ructure of the AP4-24H11 Fab in complex with AIP-4 at 2.5 A resolution to determine its mechanism of

294 beta in this model, which is consistent with AIP-1 enhancing protein degradation.

295 We analyzed data from 122 individuals with AIP who were followed from 2003 to 2013 and genotyped fo

296 ns-autophosphorylation upon interaction with AIP.

297 sed in pancreatic tissues from patients with AIP, compared with controls, and expression of chemokine

298 ligands might be used to treat patients with AIP.

299 Treatment with AIP also normalized the higher frequency of NMDAR-mediat

300 serum samples from patients with and without AIP.